CYCLOLAB CYCLODEXTRIN R&D LABORATORY LTD
Desconocido
SUPREME: Polymeric Cyclodextrin-Based Supramolecular Constructs Photoreleasing Nitric Oxide for Combating Ant...
CYCLOLAB CIKLODEXTRIN KUTATOFEJLESZTO KFT
participó en un
HORIZON EUROPE
HORIZON-MSCA-2021-PF-01
With more than 13 million people dying per year from infectious diseases Multidrug Resistance (MDR) in bacteria remains the
greatest challen...
2022-07-22 - 2024-07-31 | Financiado
2022-07-22 - 2024-07-31 | Financiado
TORNADO: Molecular Targets Open for Regulation by the gut flora New Avenues for improved Diet to Optimize E...
CYCLOLAB CIKLODEXTRIN KUTATOFEJLESZTO KFT
participó en un
FP7
Europe is facing major diet related health problems. Attitudes to eating habits have to be changed and the benefits of alternative treatment...
Financiado
Financiado
CYCLON: Novel multifunctional cyclodextrin based nanocarriers for drug encapsulation and delivery as a strat...
CYCLOLAB CIKLODEXTRIN KUTATOFEJLESZTO KFT
participó en un
FP7
There is a high demand for the development of new drug delivery strategies to combat major diseases in our society, particularly cancer. Cur...
Financiado
Financiado
CYCLON HIT: NANOCARRIERS FOR THE DELIVERY OF ANTIMICROBIAL AGENTS TO FIGHT RESISTANCE MECHANISMS
CYCLOLAB CIKLODEXTRIN KUTATOFEJLESZTO KFT
participó en un
FP7
The worldwide spread of antibiotic-resistant microorganisms can be viewed as an ecological consequence of the systematic use of antimicrobia...
Financiado
Financiado
* No se disponen de datos de la empresa actual.